$0.4180
-0.0072-1.69%
At close: Jun 9, 5:00 PM EST
$0.4180
N/A
After Hours: 7:59 PM EST
GT Biopharma Inc Earnings Estimates
GTBPNASDAQ
GT Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:GTBP
GT Biopharma (GTBP) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-0.08 and quarterly revenue of N/A.
In the most recent quarter (Q1), GT Biopharma reported EPS of $-0.11, missing estimates of $-0.08 by 0.38%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
GT Biopharma has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, GT Biopharma has averaged an EPS surprise of 0.66% and a revenue surprise of 0.00%.
Earnings Date
Aug 13
EPS Estimate
$-0.080
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
GT Biopharma Earnings History
Analyze the earnings history of GT Biopharma using advanced sorting and filters.
Loading calendar...
GT Biopharma (GTBP) Earnings Per Share
The chart below shows GT Biopharma's reported EPS compared to analyst estimates over recent quarters.
GT Biopharma (GTBP) Revenue
The chart below shows GT Biopharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is GT Biopharma (NASDAQ:GTBP) reporting earnings?
GT Biopharma (GTBP) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for GT Biopharma (NASDAQ:GTBP)?
The Actual EPS was $-0.11, which missed the estimate of $-0.08.
What were GT Biopharma’s (NASDAQ:GTBP) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
